Insider Transactions in Q2 2024 at Bio Affinity Technologies, Inc. (BIAF)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 12
2024
|
Gary D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+6.85%
|
-
|
Jun 12
2024
|
Robert A. Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+5.99%
|
-
|
Jun 12
2024
|
Peter S Knight Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+9.02%
|
-
|
Jun 12
2024
|
Jamie Platt Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+28.35%
|
-
|
Jun 12
2024
|
Roby Joyce Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+20.17%
|
-
|
Jun 12
2024
|
Maria Zannes President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+3.81%
|
-
|
Jun 12
2024
|
Steven Girgenti Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+0.8%
|
-
|
Jun 12
2024
|
Stuart Diamond Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,296
+11.27%
|
-
|
Apr 08
2024
|
Maria Zannes President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,264
-12.32%
|
$56,528
$2.65 P/Share
|
Apr 08
2024
|
Maria Zannes President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+22.03%
|
$64,848
$1.16 P/Share
|
Apr 04
2024
|
Timothy P Zannes Secretary, EVP, Gen. Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
29,031
-38.63%
|
$58,062
$2.58 P/Share
|
Apr 04
2024
|
Timothy P Zannes Secretary, EVP, Gen. Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+46.32%
|
$64,848
$1.16 P/Share
|
Apr 03
2024
|
Steven Girgenti Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
33,438
-3.16%
|
$66,876
$2.24 P/Share
|
Apr 03
2024
|
Steven Girgenti Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
64,848
+5.78%
|
$64,848
$1.16 P/Share
|